Why did Edgewise's operating expenses surge in Q4 2024?

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) did not experience a surge in operating expenses in Q4 2024. In fact, the company's operating expenses were well-managed, and no significant increases were reported.